Global Somatostatin Analogs Market Research Report 2023

Report ID: 1989686 | Published Date: Jan 2025 | No. of Page: 71 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Somatostatin Analogs Market Overview
    1.1 Product Overview and Scope of Somatostatin Analogs
    1.2 Somatostatin Analogs Segment by Type
        1.2.1 Global Somatostatin Analogs Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Octreotide
        1.2.3 Lanreotide
        1.2.4 Pasireotide
    1.3 Somatostatin Analogs Segment by Application
        1.3.1 Global Somatostatin Analogs Sales Comparison by Application: (2022-2028)
        1.3.2 Acromegaly
        1.3.3 Carcinoid Syndrome
        1.3.4 Neuroendocrine Tumor
        1.3.5 Cushing Syndrome
        1.3.6 Others
    1.4 Global Somatostatin Analogs Market Size Estimates and Forecasts
        1.4.1 Global Somatostatin Analogs Revenue 2017-2028
        1.4.2 Global Somatostatin Analogs Sales 2017-2028
        1.4.3 Somatostatin Analogs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Somatostatin Analogs Market Competition by Manufacturers
    2.1 Global Somatostatin Analogs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Somatostatin Analogs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Somatostatin Analogs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Somatostatin Analogs Manufacturing Sites, Area Served, Product Type
    2.5 Somatostatin Analogs Market Competitive Situation and Trends
        2.5.1 Somatostatin Analogs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Somatostatin Analogs Players Market Share by Revenue
        2.5.3 Global Somatostatin Analogs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Somatostatin Analogs Retrospective Market Scenario by Region
    3.1 Global Somatostatin Analogs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Somatostatin Analogs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Somatostatin Analogs Market Facts & Figures by Country
        3.3.1 North America Somatostatin Analogs Sales by Country
        3.3.2 North America Somatostatin Analogs Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Somatostatin Analogs Market Facts & Figures by Country
        3.4.1 Europe Somatostatin Analogs Sales by Country
        3.4.2 Europe Somatostatin Analogs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Somatostatin Analogs Market Facts & Figures by Region
        3.5.1 Asia Pacific Somatostatin Analogs Sales by Region
        3.5.2 Asia Pacific Somatostatin Analogs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Somatostatin Analogs Market Facts & Figures by Country
        3.6.1 Latin America Somatostatin Analogs Sales by Country
        3.6.2 Latin America Somatostatin Analogs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Somatostatin Analogs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Somatostatin Analogs Sales by Country
        3.7.2 Middle East and Africa Somatostatin Analogs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Somatostatin Analogs Historic Market Analysis by Type
    4.1 Global Somatostatin Analogs Sales Market Share by Type (2017-2022)
    4.2 Global Somatostatin Analogs Revenue Market Share by Type (2017-2022)
    4.3 Global Somatostatin Analogs Price by Type (2017-2022)
5 Global Somatostatin Analogs Historic Market Analysis by Application
    5.1 Global Somatostatin Analogs Sales Market Share by Application (2017-2022)
    5.2 Global Somatostatin Analogs Revenue Market Share by Application (2017-2022)
    5.3 Global Somatostatin Analogs Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Novartis
        6.1.1 Novartis Corporation Information
        6.1.2 Novartis Description and Business Overview
        6.1.3 Novartis Somatostatin Analogs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Novartis Somatostatin Analogs Product Portfolio
        6.1.5 Novartis Recent Developments/Updates
    6.2 Peptron
        6.2.1 Peptron Corporation Information
        6.2.2 Peptron Description and Business Overview
        6.2.3 Peptron Somatostatin Analogs Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Peptron Somatostatin Analogs Product Portfolio
        6.2.5 Peptron Recent Developments/Updates
    6.3 Chiasma
        6.3.1 Chiasma Corporation Information
        6.3.2 Chiasma Description and Business Overview
        6.3.3 Chiasma Somatostatin Analogs Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Chiasma Somatostatin Analogs Product Portfolio
        6.3.5 Chiasma Recent Developments/Updates
    6.4 Ipsen Biopharmaceutical
        6.4.1 Ipsen Biopharmaceutical Corporation Information
        6.4.2 Ipsen Biopharmaceutical Description and Business Overview
        6.4.3 Ipsen Biopharmaceutical Somatostatin Analogs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Ipsen Biopharmaceutical Somatostatin Analogs Product Portfolio
        6.4.5 Ipsen Biopharmaceutical Recent Developments/Updates
7 Somatostatin Analogs Manufacturing Cost Analysis
    7.1 Somatostatin Analogs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Somatostatin Analogs
    7.4 Somatostatin Analogs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Somatostatin Analogs Distributors List
    8.3 Somatostatin Analogs Customers
9 Somatostatin Analogs Market Dynamics
    9.1 Somatostatin Analogs Industry Trends
    9.2 Somatostatin Analogs Market Drivers
    9.3 Somatostatin Analogs Market Challenges
    9.4 Somatostatin Analogs Market Restraints
10 Global Market Forecast
    10.1 Somatostatin Analogs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Somatostatin Analogs by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Somatostatin Analogs by Type (2023-2028)
    10.2 Somatostatin Analogs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Somatostatin Analogs by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Somatostatin Analogs by Application (2023-2028)
    10.3 Somatostatin Analogs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Somatostatin Analogs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Somatostatin Analogs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Somatostatin Analogs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Somatostatin Analogs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Somatostatin Analogs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Somatostatin Analogs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Somatostatin Analogs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Somatostatin Analogs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Somatostatin Analogs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Somatostatin Analogs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Somatostatin Analogs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Somatostatin Analogs Manufacturing Sites and Area Served
    Table 11. Manufacturers Somatostatin Analogs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Somatostatin Analogs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin Analogs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Somatostatin Analogs Sales by Region (2017-2022) & (K Units)
    Table 16. Global Somatostatin Analogs Sales Market Share by Region (2017-2022)
    Table 17. Global Somatostatin Analogs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Somatostatin Analogs Revenue Market Share by Region (2017-2022)
    Table 19. North America Somatostatin Analogs Sales by Country (2017-2022) & (K Units)
    Table 20. North America Somatostatin Analogs Sales Market Share by Country (2017-2022)
    Table 21. North America Somatostatin Analogs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Somatostatin Analogs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Somatostatin Analogs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Somatostatin Analogs Sales Market Share by Country (2017-2022)
    Table 25. Europe Somatostatin Analogs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Somatostatin Analogs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Somatostatin Analogs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Somatostatin Analogs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Somatostatin Analogs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Somatostatin Analogs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Somatostatin Analogs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Somatostatin Analogs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Somatostatin Analogs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Somatostatin Analogs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Somatostatin Analogs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Somatostatin Analogs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Somatostatin Analogs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Somatostatin Analogs Revenue Market Share by Country (2017-2022)
    Table 39. Global Somatostatin Analogs Sales by Type (2017-2022) & (K Units)
    Table 40. Global Somatostatin Analogs Sales Market Share by Type (2017-2022)
    Table 41. Global Somatostatin Analogs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Somatostatin Analogs Revenue Share by Type (2017-2022)
    Table 43. Global Somatostatin Analogs Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Somatostatin Analogs Sales (K Units) by Application (2017-2022)
    Table 45. Global Somatostatin Analogs Sales Market Share by Application (2017-2022)
    Table 46. Global Somatostatin Analogs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Somatostatin Analogs Revenue Share by Application (2017-2022)
    Table 48. Global Somatostatin Analogs Price by Application (2017-2022) & (USD/Unit)
    Table 49. Novartis Corporation Information
    Table 50. Novartis Description and Business Overview
    Table 51. Novartis Somatostatin Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Novartis Somatostatin Analogs Product
    Table 53. Novartis Recent Developments/Updates
    Table 54. Peptron Corporation Information
    Table 55. Peptron Description and Business Overview
    Table 56. Peptron Somatostatin Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Peptron Somatostatin Analogs Product
    Table 58. Peptron Recent Developments/Updates
    Table 59. Chiasma Corporation Information
    Table 60. Chiasma Description and Business Overview
    Table 61. Chiasma Somatostatin Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Chiasma Somatostatin Analogs Product
    Table 63. Chiasma Recent Developments/Updates
    Table 64. Ipsen Biopharmaceutical Corporation Information
    Table 65. Ipsen Biopharmaceutical Description and Business Overview
    Table 66. Ipsen Biopharmaceutical Somatostatin Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Ipsen Biopharmaceutical Somatostatin Analogs Product
    Table 68. Ipsen Biopharmaceutical Recent Developments/Updates
    Table 69. Production Base and Market Concentration Rate of Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. Somatostatin Analogs Distributors List
    Table 72. Somatostatin Analogs Customers List
    Table 73. Somatostatin Analogs Market Trends
    Table 74. Somatostatin Analogs Market Drivers
    Table 75. Somatostatin Analogs Market Challenges
    Table 76. Somatostatin Analogs Market Restraints
    Table 77. Global Somatostatin Analogs Sales Forecast by Type (2023-2028) & (K Units)
    Table 78. Global Somatostatin Analogs Sales Market Share Forecast by Type (2023-2028)
    Table 79. Global Somatostatin Analogs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 80. Global Somatostatin Analogs Revenue Market Share Forecast by Type (2023-2028)
    Table 81. Global Somatostatin Analogs Sales Forecast by Application (2023-2028) & (K Units)
    Table 82. Global Somatostatin Analogs Sales Market Share Forecast by Application (2023-2028)
    Table 83. Global Somatostatin Analogs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 84. Global Somatostatin Analogs Revenue Market Share Forecast by Application (2023-2028)
    Table 85. Global Somatostatin Analogs Sales Forecast by Region (2023-2028) & (K Units)
    Table 86. Global Somatostatin Analogs Sales Market Share Forecast by Region (2023-2028)
    Table 87. Global Somatostatin Analogs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 88. Global Somatostatin Analogs Revenue Market Share Forecast by Region (2023-2028)
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Somatostatin Analogs
    Figure 2. Global Somatostatin Analogs Market Share by Type in 2021 & 2028
    Figure 3. Octreotide Product Picture
    Figure 4. Lanreotide Product Picture
    Figure 5. Pasireotide Product Picture
    Figure 6. Global Somatostatin Analogs Market Share by Application in 2021 & 2028
    Figure 7. Acromegaly
    Figure 8. Carcinoid Syndrome
    Figure 9. Neuroendocrine Tumor
    Figure 10. Cushing Syndrome
    Figure 11. Others
    Figure 12. Global Somatostatin Analogs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Somatostatin Analogs Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Somatostatin Analogs Sales (2017-2028) & (K Units)
    Figure 15. Somatostatin Analogs Sales Share by Manufacturers in 2021
    Figure 16. Global Somatostatin Analogs Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Somatostatin Analogs Players: Market Share by Revenue in 2021
    Figure 18. Somatostatin Analogs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Somatostatin Analogs Sales Market Share by Region (2017-2022)
    Figure 20. Global Somatostatin Analogs Sales Market Share by Region in 2021
    Figure 21. Global Somatostatin Analogs Revenue Market Share by Region (2017-2022)
    Figure 22. Global Somatostatin Analogs Revenue Market Share by Region in 2021
    Figure 23. U.S. Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Taiwan Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Philippines Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Vietnam Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Mexico Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Brazil Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Argentina Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Turkey Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Saudi Arabia Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. U.A.E Somatostatin Analogs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Sales Market Share of Somatostatin Analogs by Type (2017-2022)
    Figure 48. Manufacturing Cost Structure of Somatostatin Analogs
    Figure 49. Manufacturing Process Analysis of Somatostatin Analogs
    Figure 50. Somatostatin Analogs Industrial Chain Analysis
    Figure 51. Channels of Distribution
    Figure 52. Distributors Profiles
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Peptron
Chiasma
Ipsen Biopharmaceutical
Frequently Asked Questions
Somatostatin Analogs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Somatostatin Analogs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Somatostatin Analogs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Touch Screen Glove

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More